Evolution of Small Molecule Kinase Drugs
Author:
Affiliation:
1. IMED Biotech Unit,Discovery Sciences, AstraZeneca, Alderley Park SK10 4TG, U.K.
2. Oncology, IMED Biotech Unit, Medicinal Chemistry, AstraZeneca, Cambridge CB4 0WG, U.K.
3. Novartis Pharma AG, Novartis Campus, 4002 Basel, Switzerland
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.8b00445
Reference50 articles.
1. Ten things you should know about protein kinases: IUPHAR Review 14
2. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases
3. FDA-approved small-molecule kinase inhibitors
4. Kinase Drug Discovery – What’s Next in the Field?
5. Kinase-targeted cancer therapies: progress, challenges and future directions
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Occurrence of “Natural Selection” in Successful Small Molecule Drug Discovery;Journal of Medicinal Chemistry;2024-07-01
2. Innovative strategies for measuring kinase activity to accelerate the next wave of novel kinase inhibitors;Drug Discovery Today;2024-03
3. An essential Trypanosoma brucei protein kinase: a functional analysis of regulation and the identification of inhibitors;Frontiers in Parasitology;2023-11-14
4. Synthesis of 6-CF3-1,2,4-triazine-based Tyrosine Kinase Inhibitors and The Evaluation of Biological Activities★;Acta Chimica Sinica;2023
5. Targeting Janus Kinase (JAK) for Fighting Diseases: The Research of JAK Inhibitor Drugs;Current Medicinal Chemistry;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3